We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$43.7M
(+43%)
Cap. Flow
+$49.2M
Cap. Flow
% of AUM
33.95%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
223
New
58
Increased
36
Reduced
83
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$6.28M |
| 2 |
Centene
CNC
|
+$3.55M |
| 3 |
Harmony Biosciences
HRMY
|
+$3.07M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
+$2.84M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aurinia Pharmaceuticals
AUPH
|
+$2.42M |
| 2 |
PennyMac Financial
PFSI
|
+$1.76M |
| 3 |
AirSculpt Technologies
AIRS
|
+$1.33M |
| 4 |
Starwood Property Trust
STWD
|
+$1.19M |
| 5 |
Ametek
AME
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.03% |
| 2 | Real Estate | 10.47% |
| 3 | Financials | 4.37% |
| 4 | Energy | 4.28% |
| 5 | Technology | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insmed
INSM
$23.5B
| $1.44M | 0.99% |
84,500
+64,500
| +323% | +$1.25M |
|
|
DX
27
Dynex Capital
DX
$2.87B
| $1.44M | 0.99% |
118,590
+35,000
| +42% | +$468K |
|
28
Procept Biorobotics
PRCT
$1.09B
| $1.42M | 0.98% |
50,000
| – | – |
|
|
ITCI
29
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.38M | 0.95% |
25,500
+18,000
| +240% | +$870K |
|
30
AeroVironment
AVAV
$7.2B
| $1.37M | 0.95% |
15,000
| – | – |
|
31
Allient
ALNT
$1.49B
| $1.35M | 0.93% |
35,000
-2,500
| -7% | -$99K |
|
32
Intuitive Surgical
ISRG
$122B
| $1.28M | 0.88% |
5,000
| – | – |
|
33
Alkermes
ALKS
$8.79B
| $1.27M | 0.88% |
+45,000
| New | +$1.23M |
|
34
Fulgent Genetics
FLGT
$573M
| $1.23M | 0.85% |
39,500
| – | – |
|
35
Collegium Pharmaceutical
COLL
$1.17B
| $1.19M | 0.82% |
49,500
| – | – |
|
|
AMYT
36
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $1.18M | 0.82% |
81,000
| – | – |
|
37
Ultragenyx Pharmaceutical
RARE
$2.88B
| $1.14M | 0.79% |
28,500
+1,500
| +6% | +$64.4K |
|
38
Stereotaxis
STXS
$154M
| $1.12M | 0.77% |
550,000
+50,000
| +10% | +$112K |
|
|
DCPH
39
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.12M | 0.77% |
+72,500
| New | +$1.21M |
|
|
VRNA
40
DELISTED
Verona Pharma
VRNA
| $1.1M | 0.76% |
55,000
| – | – |
|
|
PETQ
41
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.09M | 0.75% |
95,000
| – | – |
|
42
Mobileye
MBLY
$7.76B
| $1.08M | 0.75% |
25,000
| – | – |
|
|
DVAX
43
DELISTED
Dynavax Technologies
DVAX
| $1.05M | 0.73% |
107,500
+71,500
| +199% | +$763K |
|
44
Accuray
ARAY
$30.8M
| $1.04M | 0.72% |
350,000
| – | – |
|
45
Novavax
NVAX
$1.35B
| $1.04M | 0.72% |
150,000
+45,000
| +43% | +$414K |
|
46
DocGo
DCGO
$64.3M
| $1.04M | 0.72% |
120,000
+10,000
| +9% | +$88.2K |
|
47
Jazz Pharmaceuticals
JAZZ
$15.5B
| $1.02M | 0.71% |
7,000
+3,500
| +100% | +$518K |
|
|
RWT
48
Redwood Trust
RWT
$641M
| $988K | 0.68% |
146,593
+15,195
| +12% | +$114K |
|
|
WBA
49
DELISTED
Walgreens Boots Alliance
WBA
| $968K | 0.67% |
28,000
+16,000
| +133% | +$568K |
|
|
ONIT
50
Onity Group
ONIT
$344M
| $966K | 0.67% |
35,618
| – | – |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, AlphaCentric Advisors held 223 positions worth $145M, up 43% from $101M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AlphaCentric Advisors deployed $49.2M of net new capital in Q1 2023, opening 58 new positions and adding to 36 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 57% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Aurinia Pharmaceuticals, an estimated $2.42M trimmed.
- AlphaCentric Advisors's largest Q1 2023 buy was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.
- AlphaCentric Advisors added most to BioCryst Pharmaceuticals in Q1 2023, an estimated $2.84M increase.
- AlphaCentric Advisors's biggest Q1 2023 reduction was Aurinia Pharmaceuticals, cutting an estimated $2.42M.
- AlphaCentric Advisors fully exited PennyMac Financial in Q1 2023, selling an estimated $1.76M.
- AlphaCentric Advisors's ten largest holdings make up 24% of its $145M portfolio in Q1 2023.
- AlphaCentric Advisors opened 58 new positions and closed 14 in Q1 2023.
- AlphaCentric Advisors's portfolio value rose 43% quarter-over-quarter to $145M.
Based on AlphaCentric Advisors's 13F filing for Q1 2023, filed 12 May 2023.